Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells.
Nagaya N, Kangawa K, Kanda M, Uematsu M, Horio T, Fukuyama N, Hino J, Harada-Shiba M, Okumura H, Tabata Y, Mochizuki N, Chiba Y, Nishioka K, Miyatake K, Asahara T, Hara H, Mori H.
Nagaya N, et al. Among authors: miyatake k.
Circulation. 2003 Aug 19;108(7):889-95. doi: 10.1161/01.CIR.0000079161.56080.22. Epub 2003 Jun 30.
Circulation. 2003.
PMID: 12835224